The 10th World Congress on Controversies
in Ophthalmology (COPHy)
On behalf of the COPHY Chairs, Prof. Anat Loewenstein and Prof. Neil Bressler, we would like to announce that preparations for The 10th World Congress on Controversies in Ophthalmology (COPHy) which will take place in Dublin, Ireland on April 4-6, 2019, and The 5thAnnual Congress on Controversies Ophthalmology: Asia Australia (COPHy AA) to take place in Shanghai, China on February 21- 23, 2019 are well under way.
The great success of the previous COPHy EU and COPHy AA Congresses, held across Europe and Asia-Pacific, as well as the enthusiastic feedback received from the most recent Congresses, confirmed the need for proceeding with the 10th edition of COPHy EU and the 5th edition of COPHy AA.
Something for the weekend…
ISGEDR is sponsoring a symposium of treatment of inherited retinal diseases at the World OCular Congress which is starting this Friday in the amazing city of Barcelona.
For full programme and booking details head to the event website at WOC-2018
HD Screencasts from last years highly-successful ISGEDR and Joint UK EGG Meeting are available now on our Screencasts Page.
Dates and Location Set for ISOO 2019
International Society of Ocular Oncology Biennial Conference
March 22nd to 26th, 2019
The Ritz Marina del Rey, Los Angeles
The ISOO executive and program committee is pleased to announce that registration is now open for the 2019 ISOO meeting: http://www.isoo2019.com/registration/
The program committee is working hard to put together an informative, collaborative and fun meeting in Los Angeles. Highlights this year include a green meeting, hot topics requests from YOU, practical morning sessions for Young Ocular Oncologists (YOOs) & trainees and the 3rd meeting of Women in Ocular Oncology (WOOs). We have three esteemed invited lecturers: Dr. Tim Sullivan, Dr. Brenda Gallie (The Murphree Lecture) & Dr. John Hungerford (The Stallard Lecture)
We will continue to offer a collaborative working day and research update on Friday March 22nd which is included in the registration and open to all members as well as a Pathology course for a nominal fee which sponsored by the ISOO/AAOOP and University of Southern California.
All meeting events will take place at the Ritz in gorgeous Marina del Rey! A block of rooms has been reserved at >50% off rack rates with water views from all rooms– to avoid LA traffic we HIGHLY encourage you to book on site ASAP and spend the week enjoying discussions, collaborations, and sunshine with your colleagues.
Please note that your ISOO membership dues must be up to date in order to attend and submit an abstract. Please visit the ISOO website www.isoo.org to pay your annual dues using your email address and password.
Call for papers coming this summer!
HD Screencasts from last years highly-successful ISGEDR and Joint UK EGG Meeting are COMING SOON.
For a flavour of the meeting, here is our Montage Video:
FDA Approves Gene Therapy for RPE65 Retinal Disease
On December 19, 2017, the FDA approved Voretigene Neparvovec (Luxturna, Spark Therapeutics), a one-time gene therapy for patients with vision loss due to RPE65-related inherited retinal disease.
AAPOS has posted an information sheet for patients and families developed by the Genetic Eye Disease Task Force, the chair of which, Dr. Arlene Drack, and several members are ISGEDR members.
For a short piece on the history of this treatment, visit the American Society for Gene and Cell Therapy at this link
For a CNBC piece on pricing of the drug visit this link
Additional helpful links for patient queries include:
- Information at Foundation Fighting Blindness: http://www.blindness.org/
- General info on gene therapy, importance of genetic testing, and living with IRDs can be found on www.ASharedVision.com
- Information on Luxturna, ocular gene therapy treatment centers, and genetic testing program can be found at www.Luxturna.com
- Information about Spark patient support services can be found at www.mysparkgeneration.com or by calling 1-833-SPARK-PS (1-833-772-7577).
Site for healthcare professionals: https://luxturnahcp.com/
XVIIIth International Symposium on Retinal Degeneration. September 3-8, 2018. Killarney, Ireland
The Travel Award application site is open now until the Deadline – May 18, 2018
Registration & Abstract submission site is now open. Abstract Deadline – June 29, 2018
See more information on our Resources Page
Professor Irene Hussels Maumenee receives the American Academy of Ophthalmology Laureate Award
The AAO honored Professor Maumenee with its highest possible award at the annual meeting in New Orleans in November, 2018. Professor Maumeneefounded ISGED (now ISGEDR) in 1978 together with Professors Cotlier of New York and Ohba from Japan. The first meeting was held in Tokyo in 1978. The society has met every two years since.
ISGEDR extends its warm and sincere congratulations to Professor Maumenee.
Very Successful Joint ISGEDR-UK EGG Meeting in Leeds, UK
Close to 200 delegates got together at the Rose Bowl in Leeds in the Sagar Wright Lecture Theatre for 3 days to share information about the diagnosis and management of genetic diseases of the eye and about retinoblastoma. The program was comprised of symposia, free paper sessions, case presentations, posters and 4 named Lectures.
News, Articles and Other Information About the Meting
The International Society for Genetic Eye Diseases and Retinoblastoma has given 4 travel grants of $1500.00 and free registration at the meeting to the following individuals:
University College London, UK
Resident in Ophthalmology
University Department of Ophthalmology
AHEPA Hospital, Thessaloniki, Greece
Resident in Ophthalmology
University of Michigan, USA
Raquel Sofia Silva
University College London, UK
Congratulations to all the recipients.